Lexeo Therapeutics, Inc. Common Stock (LXEO) Earnings Analysis
Lexeo Therapeutics, Inc. Common Stock (LXEO) next reports earnings on 2026-08-13, consensus EPS -0.3 USD. Last quarter (2026-05-11) it beat with EPS -0.25 USD vs -0.29 USD est (+13.8%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E -3.36.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does LXEO next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.3 USD |
| Revenue estimate | n/a |
LXEO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.25 USD | -0.29 USD | +13.8% | Beat |
| 2026-03-30 | -0.27 USD | -0.32 USD | +15.6% | Beat |
| 2025-08-14 | -0.6 USD | -0.64 USD | +6.3% | Beat |
| 2025-05-12 | -0.99 USD | -0.8 USD | -23.7% | Miss |
| 2025-03-24 | -0.78 USD | -0.87 USD | +10.3% | Beat |
| 2024-11-13 | -0.89 USD | -0.65 USD | -36.9% | Miss |
| 2024-08-12 | -0.64 USD | -0.69 USD | +7.2% | Beat |
Beat rate: 5/7 (71%) over reported quarters with consensus data.
LXEO valuation and analyst view
| Trailing P/E | -3.36 |
|---|---|
| Trailing EPS | -1.07781 USD |
| Price / book | 1.71 |
| Dividend yield | 0.00% |
| Market cap | 0.37B |
| Analyst consensus | Buy (5 buy / 0 hold / 0 sell) |
| Avg price target | 18.78 USD |
Related research pages
Frequently asked questions
When is Lexeo Therapeutics, Inc. Common Stock (LXEO)'s next earnings date?
Lexeo Therapeutics, Inc. Common Stock is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.3 USD.
Did LXEO beat earnings last quarter?
In its 2026-05-11 report, LXEO posted EPS of -0.25 USD versus a -0.29 USD estimate — a beat of 13.8%.
What is LXEO's earnings track record?
Over the last 7 reported quarters with consensus data, LXEO beat estimates 5 times (71%).
What is LXEO's current P/E ratio and EPS?
LXEO trades at a trailing P/E of -3.36 on trailing EPS of -1.0778133946210853 USD.
What do analysts rate LXEO?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 18.78 USD.